Table 3.
Comparison of patients treated for VUS and BNS.
VUS | BNS | p-value | |
---|---|---|---|
Age [mean years (SD)] | 67.7 (±8.48) | 69.1 (±6.45) | n.s. |
Time from initial therapy to stenosis [mean month (SD)] | 28.14 (±31.28) | 19.36 (±20.54) | n.s. |
Time from prior endoscopic therapy to recurrence [mean month (SD)] | 12.31 (±24.36) | 11.31 (±16.63) | n.s. |
Radiation therapy prior endoscopic treatment, n (%) | 29 (33.3) | 8 (13.3) | 0.006 |
Qmax, mean ml (SD) | 9.35 (±6.39) | 6.24 (±3.47) | n.s. |
PVR, mean ml (SD) | 78.54 (±87.25) | 126.63 (±31.4) | n.s. |
Recurrence, n (%) | 52 (59.8) | 25 (41.7) | 0.031 |
Time to recurrence [mean month (SD)] | 5.85 (±7.27) | 8.13 (±9.98) | n.s. |
De novo-incontinence, n (%) | 12 (13.8) | 1 (1.7) | 0.011 |
BNS, bladder neck stenosis; VUS, vesicourethral anastomosis stenosis.